longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Cogent Biosciences(COGT.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

De-Extinct Dire Wolves Ready To Breed; Bioscience Company Pushes Forward Multiple Projects

ZeroHedge·05/09/2026 23:42
US
MBX
+2.40%
US
DTIL
+3.62%
US
COGT
+4.45%
ZeroHedge·05/09/2026 23:42
US
MBX
+2.40%
US
DTIL
+3.62%
US
COGT
+4.45%

Cogent Biosciences | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/05/2026 20:10
US
COGT
+4.45%
Earnings Watch·05/05/2026 20:10
US
COGT
+4.45%

A Look At Cogent Biosciences (COGT) Valuation After New KRAS And ErbB2 Data At AACR 2026

Simplywall·04/27/2026 14:07
US
COGT
+4.45%
Simplywall·04/27/2026 14:07
US
COGT
+4.45%

Southwest Airlines, Colliers International, and more stocks see action from activist investors

MSN·04/11/2026 05:51
US
BBIO
+3.38%
US
LUV
+5.64%
US
COGT
+4.45%
MSN·04/11/2026 05:51
US
BBIO
+3.38%
US
LUV
+5.64%
US
COGT
+4.45%

Cogent Biosciences (COGT) Is Up 6.1% After FDA NDA Filing For Bezuclastinib In GIST

Simplywall·04/10/2026 18:02
US
COGT
+4.45%
Simplywall·04/10/2026 18:02
US
COGT
+4.45%

The $10B Company Behind The Dire Wolf Is Now Bringing Back Mammoths

Forbes·04/09/2026 23:30
US
LABU
+9.34%
US
ARKG
+3.59%
US
BBH
+0.45%
Forbes·04/09/2026 23:30
US
LABU
+9.34%
US
ARKG
+3.59%
US
BBH
+0.45%
© 2026 Longbridge|Disclaimer

Event Tracking

May6
Cogent Biosciences released FY2026 Q1 earnings on May 5 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5999 (forecast USD -0.5409)
03:00
May5
Cogent Biosciences Inc Reports Q1 Loss, Preparing for New Drug Launch
12:07
Apr21
Cogent Biosciences Achieves Expected Goals in Late-Stage GIST Treatment Trial
12:07
Apr17
Cogent Biosciences to Present Preclinical Updates on Oncology Programs at AACR Annual Meeting
12:03
Apr1
Cogent Biosciences' GIST drug application submission leads to 6% stock price drop
14:37
Fairmount Funds Management Reduces Holdings in Cogent Biosciences
01:31

Schedules & Filings

Schedules
Filings
May5
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -97.35 M, EPS -0.5999

Feb17
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -102.49 M, EPS -0.6829

Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -80.93 M, EPS -0.588

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
5.800
+2,365.99%
+5.565
FSHPR
0.1666
+105.43%
+0.086
HCWB
2.150
+102.83%
+1.090
GCL
0.7919
+83.44%
+0.360
SLXN
0.4880
+81.41%
+0.216
PHGE
0.6663
+78.16%
+0.292
MWC
8.350
+76.91%
+3.630
MTVA
2.680
+42.55%
+0.800
EMISR
0.1400
+39.86%
+0.040
HSPTR
0.3100
+39.01%
+0.087
View More